| 1 | Sex differences in healthcare utilization for chronic rhinosinusitis: a prospective cohort study | 1.6 | 0 | Citations (PDF) |
| 2 | IL-22Ra2 Levels Remain Elevated in People with Cystic Fibrosis despite Modulator Therapy. | 5.0 | 2 | Citations (PDF) |
| 3 | Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polyps | 5.0 | 28 | Citations (PDF) |
| 4 | Risk of new-onset and prevalent disease in chronic rhinosinusitis: A prospective cohort study | 2.1 | 13 | Citations (PDF) |
| 5 | The genetic determinants of recurrent somatic mutations in 43,693 blood genomes | 8.2 | 13 | Citations (PDF) |
| 6 | Sinus inflammation and chronic rhinosinusitis are associated with a diagnosis of new onset asthma in the following year | 4.4 | 21 | Citations (PDF) |
| 7 | Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseases | 5.7 | 19 | Citations (PDF) |
| 8 | Epigenetic responses to rhinovirus exposure in airway epithelial cells are correlated with key transcriptional pathways in chronic rhinosinusitis | 4.4 | 11 | Citations (PDF) |
| 9 | Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa | 1.6 | 27 | Citations (PDF) |
| 10 | Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches | 4.4 | 276 | Citations (PDF) |
| 11 | Elevated Serum Leptin Levels in Patients With Eosinophilic Chronic Rhinosinusitis | 2.6 | 16 | Citations (PDF) |
| 12 | Studies on activation and regulation of the coagulation cascade in chronic rhinosinusitis with nasal polyps | 5.0 | 9 | Citations (PDF) |
| 13 | Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps | 5.0 | 119 | Citations (PDF) |
| 14 | Strong and consistent associations of precedent chronic rhinosinusitis with risk of non–cystic fibrosis bronchiectasis | 5.0 | 27 | Citations (PDF) |
| 15 | Anti-phospholipid antibodies are elevated and functionally active in chronic rhinosinusitis with nasal polyps | 1.6 | 11 | Citations (PDF) |
| 16 | Mechanisms and pathogenesis of chronic rhinosinusitis | 5.0 | 290 | Citations (PDF) |
| 17 | Use of intraoperative frontal sinus mometasone-eluting stents decreased interleukin 5 and interleukin 13 in patients with chronic rhinosinusitis with nasal polyps | 2.1 | 10 | Citations (PDF) |
| 18 | CRS-PRO and SNOT-22 correlations with type 2 inflammatory mediators in chronic rhinosinusitis | 2.1 | 24 | Citations (PDF) |
| 19 | Elevation of activated neutrophils in chronic rhinosinusitis with nasal polyps | 5.0 | 62 | Citations (PDF) |
| 20 | Nasal secretion tissue plasminogen activator: A novel effective predictor of nasal polyp recurrence | 2.6 | 9 | Citations (PDF) |
| 21 | Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trial | 1.6 | 16 | Citations (PDF) |
| 22 | American Journal of Respiratory Cell and Molecular Biology | 2.1 | 8 | Citations (PDF) |
| 23 | Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease | 5.0 | 90 | Citations (PDF) |
| 24 | Mechanisms and biomarkers of inflammatory endotypes in chronic rhinosinusitis without nasal polyps | 5.0 | 116 | Citations (PDF) |
| 25 | Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody | 3.3 | 102 | Citations (PDF) |
| 26 | Targetable pathogenic mechanisms in nasal polyposis | 2.1 | 9 | Citations (PDF) |
| 27 | Prevalence and characteristics of peanut allergy in US adults | 5.0 | 67 | Citations (PDF) |
| 28 | Studies of the role of basophils in aspirin-exacerbated respiratory disease pathogenesis | 5.0 | 37 | Citations (PDF) |
| 29 | Prevalence of Bronchiectasis in Patients with Chronic Rhinosinusitis in a Tertiary Care Center | 2.6 | 25 | Citations (PDF) |
| 30 | Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitis | 1.1 | 17 | Citations (PDF) |
| 31 | Discovery, Function, and Therapeutic Targeting of Siglec-8 | 3.4 | 87 | Citations (PDF) |
| 32 | Multi-omics colocalization with genome-wide association studies reveals a context-specific genetic mechanism at a childhood onset asthma risk locus | 5.9 | 47 | Citations (PDF) |
| 33 | Epithelial-Cell-Derived Extracellular Vesicles in Pathophysiology of Epithelial Injury and Repair in Chronic Rhinosinusitis: Connecting Immunology in Research Lab to Biomarkers in Clinics | 3.2 | 11 | Citations (PDF) |
| 34 | TNF induces production of type 2 cytokines in human group 2 innate lymphoid cells | 5.0 | 8 | Citations (PDF) |
| 35 | Radiologic sinus inflammation and symptoms of chronic rhinosinusitis in a population-based sample | 4.4 | 51 | Citations (PDF) |
| 36 | Development and Preliminary Validation of a New Patient-Reported Outcome Measure for Chronic Rhinosinusitis (CRS-PRO) | 2.6 | 34 | Citations (PDF) |
| 37 | Association of chronic rhinosinusitis with high microbiome dissimilarity among different patients and within individuals over time | 0.9 | 4 | Citations (PDF) |
| 38 | Adult chronic rhinosinusitis | 39.8 | 310 | Citations (PDF) |
| 39 | Inhibition of the non-gastric H+/K+-ATPase (ATP12A) by ilaprazole and vonoprazan decreased IL-13-stimulated eotaxin-3 expression in airway epithelial cells. | 5.0 | 1 | Citations (PDF) |
| 40 | Integrin β6 microparticles in nasal lavage fluids; potential new biomarkers for basal cell activation in chronic rhinosinusitis | 4.4 | 7 | Citations (PDF) |
| 41 | Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19 | 5.0 | 266 | Citations (PDF) |
| 42 | Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin | 5.0 | 165 | Citations (PDF) |
| 43 | Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop | 2.6 | 49 | Citations (PDF) |
| 44 | A new approach to categorization of radiologic inflammation in chronic rhinosinusitis | 1.5 | 6 | Citations (PDF) |
| 45 | Responsiveness and Convergent Validity of a New Patient-Reported Outcome Measure for Chronic Rhinosinusitis (CRS-PRO) | 2.6 | 23 | Citations (PDF) |
| 46 | Common fibrin deposition and tissue plasminogen activator downregulation in nasal polyps with distinct inflammatory endotypes | 5.0 | 34 | Citations (PDF) |
| 47 | Clinical factors associated with acute exacerbations of chronic rhinosinusitis. | 5.0 | 39 | Citations (PDF) |
| 48 | Increased expression of L-plastin in nasal polyp of patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease | 4.4 | 23 | Citations (PDF) |
| 49 | Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis | 2.6 | 431 | Citations (PDF) |
| 50 | Prevalence and characterization of chronic rhinosinusitis in patients with non‒cystic fibrosis bronchiectasis at a tertiary care center in the United States | 2.1 | 26 | Citations (PDF) |
| 51 | Increased thrombin-activatable fibrinolysis inhibitor levels in patients with chronic rhinosinusitis with nasal polyps | 5.0 | 29 | Citations (PDF) |
| 52 | Identification of whole blood mRNA and microRNA biomarkers of tissue damage and immune function resulting from amphetamine exposure or heat stroke in adult male rats | 1.5 | 8 | Citations (PDF) |
| 53 | Workplace Indirect Cost Impacts of Nasal and Sinus Symptoms and Related Conditions | 0.7 | 7 | Citations (PDF) |
| 54 | Clinical Characteristics of Patients with Chronic Rhinosinusitis without Nasal Polyps in an Academic Setting | 2.6 | 132 | Citations (PDF) |
| 55 | Prevalence and Severity of Food Allergies Among US Adults | 5.2 | 979 | Citations (PDF) |
| 56 | Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes | 0.9 | 129 | Citations (PDF) |
| 57 | Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps | 3.0 | 43 | Citations (PDF) |
| 58 | Mast cell–derived plasminogen activator inhibitor type 1 promotes airway inflammation and remodeling in a murine model of asthma | 5.0 | 14 | Citations (PDF) |
| 59 | Longitudinal Evaluation of Chronic Rhinosinusitis Symptoms in a Population-Based Sample | 2.6 | 18 | Citations (PDF) |
| 60 | Asthma onset pattern and patient outcomes in a chronic rhinosinusitis population | 2.1 | 44 | Citations (PDF) |
| 61 | Pathogenic and protective roles of B cells and antibodies in patients with chronic rhinosinusitis | 5.0 | 40 | Citations (PDF) |
| 62 | The nasal microbiome in patients with chronic rhinosinusitis: Analyzing the effects of atopy and bacterial functional pathways in 111 patients | 5.0 | 71 | Citations (PDF) |
| 63 | IL-10, TGF-β, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells | 5.0 | 46 | Citations (PDF) |
| 64 | Epithelial activators of type 2 inflammation: Elevation of thymic stromal lymphopoietin, but not IL-25 or IL-33, in chronic rhinosinusitis with nasal polyps in Chicago, Illinois | 4.4 | 51 | Citations (PDF) |
| 65 | Association of nasal microbiome and asthma control in patients with chronic rhinosinusitis | 1.6 | 16 | Citations (PDF) |
| 66 | Proprotein convertases generate a highly functional heterodimeric form of thymic stromal lymphopoietin in humans | 5.0 | 42 | Citations (PDF) |
| 67 | The Clinical Significance of Specific Antibody Deficiency (SAD) Severity in Chronic Rhinosinusitis (CRS) | 2.6 | 55 | Citations (PDF) |
| 68 | Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease | 2.6 | 254 | Citations (PDF) |
| 69 | Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease | 5.0 | 44 | Citations (PDF) |
| 70 | Sleep disruption in chronic rhinosinusitis | 2.4 | 53 | Citations (PDF) |
| 71 | American Journal of Respiratory Cell and Molecular Biology | 2.1 | 19 | Citations (PDF) |
| 72 | Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps | 1.9 | 130 | Citations (PDF) |
| 73 | Risk of obstructive sleep apnea in African American patients with chronic rhinosinusitis | 0.9 | 38 | Citations (PDF) |
| 74 | Evidence for altered levels of IgD in the nasal airway mucosa of patients with chronic rhinosinusitis | 5.0 | 26 | Citations (PDF) |
| 75 | Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases | 5.0 | 185 | Citations (PDF) |
| 76 | Regulatory T-cell populations in children are affected by age and food allergy diagnosis. | 5.0 | 19 | Citations (PDF) |
| 77 | Superior turbinate eosinophilia correlates with olfactory deficit in chronic rhinosinusitis patients | 0.8 | 66 | Citations (PDF) |
| 78 | Evaluating metrics of responsiveness using patient-reported outcome measures in chronic rhinosinusitis | 2.1 | 18 | Citations (PDF) |
| 79 | Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease | 5.0 | 147 | Citations (PDF) |
| 80 | Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis | 20.5 | 523 | Citations (PDF) |
| 81 | Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis | 5.0 | 43 | Citations (PDF) |
| 82 | A prospective analysis evaluating tissue biopsy location and its clinical relevance in chronic rhinosinusitis with nasal polyps | 2.1 | 25 | Citations (PDF) |
| 83 | The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease | 3.6 | 84 | Citations (PDF) |
| 84 | Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPase | 5.0 | 79 | Citations (PDF) |
| 85 | Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois | 5.0 | 181 | Citations (PDF) |
| 86 | Granulocyte colony-stimulating factor blockade enables dexamethasone to inhibit lipopolysaccharide-induced murine lung neutrophils | 1.5 | 9 | Citations (PDF) |
| 87 | Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression | 1.5 | 34 | Citations (PDF) |
| 88 | Chronic Rhinosinusitis with Nasal Polyps | 2.6 | 524 | Citations (PDF) |
| 89 | A pilot study of symptom profiles from a polyp vs an eosinophilic-based classification of chronic rhinosinusitis | 2.1 | 55 | Citations (PDF) |
| 90 | A Recently Established Murine Model of Nasal Polyps Demonstrates Activation of B Cells, as Occurs in Human Nasal Polyps. | 2.1 | 17 | Citations (PDF) |
| 91 | The quest for autoreactive antibodies in nasal polyps | 5.0 | 24 | Citations (PDF) |
| 92 | Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis | 1.5 | 46 | Citations (PDF) |
| 93 | Allergens stimulate store-operated calcium entry and cytokine production in airway epithelial cells | 2.7 | 55 | Citations (PDF) |
| 94 | Prevalence of allergic rhinitis and asthma in patients with chronic rhinosinusitis and gastroesophageal reflux disease | 0.9 | 21 | Citations (PDF) |
| 95 | African American Patients with Chronic Rhinosinusitis Have a Distinct Phenotype of Polyposis Associated with Increased Asthma Hospitalization | 2.6 | 35 | Citations (PDF) |
| 96 | American Journal of Respiratory Cell and Molecular Biology | 2.1 | 38 | Citations (PDF) |
| 97 | Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease | 5.0 | 151 | Citations (PDF) |
| 98 | Chronic rhinosinusitis pathogenesis | 5.0 | 345 | Citations (PDF) |
| 99 | Increased noneosinophilic nasal polyps in chronic rhinosinusitis in US second-generation Asians suggest genetic regulation of eosinophilia | 5.0 | 113 | Citations (PDF) |
| 100 | Clinical Characteristics of Adults With Chronic Rhinosinusitis and Specific Antibody Deficiency | 2.6 | 47 | Citations (PDF) |
| 101 | Genome-wide association study identifies peanut allergy-specific loci and evidence of epigenetic mediation in US children | 11.0 | 231 | Citations (PDF) |
| 102 | Cross-talk between human mast cells and bronchial epithelial cells in plasminogen activator inhibitor-1 production via transforming growth factor-β1. | 2.1 | 28 | Citations (PDF) |
| 103 | The Etiology and Pathogenesis of Chronic Rhinosinusitis: a Review of Current Hypotheses | 3.6 | 213 | Citations (PDF) |
| 104 | American Journal of Respiratory and Critical Care Medicine | 5.0 | 283 | Citations (PDF) |
| 105 | Association of common filaggrin null mutations with atopy but not chronic rhinosinusitis | 0.9 | 1 | Citations (PDF) |
| 106 | Expression of ligands for Siglec-8 and Siglec-9 in human airways and airway cells | 5.0 | 62 | Citations (PDF) |
| 107 | Increased expression of the epithelial anion transporter pendrin/SLC26A4 in nasal polyps of patients with chronic rhinosinusitis | 5.0 | 64 | Citations (PDF) |
| 108 | A retrospective, cross-sectional study reveals that women with CRSwNP have more severe disease than men | 1.9 | 62 | Citations (PDF) |
| 109 | American Journal of Respiratory Cell and Molecular Biology | 2.1 | 23 | Citations (PDF) |
| 110 | American Journal of Respiratory Cell and Molecular Biology | 2.1 | 15 | Citations (PDF) |
| 111 | Evaluating the Stability of RNA-Seq Transcriptome Profiles and Drug-Induced Immune-Related Expression Changes in Whole Blood | 1.5 | 18 | Citations (PDF) |
| 112 | Stimulus-Selective Regulation of Human Mast Cell Gene Expression, Degranulation and Leukotriene Production by Fluticasone and Salmeterol | 1.5 | 5 | Citations (PDF) |
| 113 | Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity | 5.0 | 90 | Citations (PDF) |
| 114 | American Journal of Respiratory Cell and Molecular Biology | 2.1 | 69 | Citations (PDF) |
| 115 | Plasminogen activator inhibitor-1 in sputum and nasal lavage fluids increases in asthmatic patients during common colds | 5.0 | 10 | Citations (PDF) |
| 116 | Biology of nasal polyposis | 5.0 | 32 | Citations (PDF) |
| 117 | Aspergillus Fumigatus May Promote Th2 Activation By Suppression Of Interferon Signaling | 5.0 | 2 | Citations (PDF) |
| 118 | Suppressor of cytokine signaling 3 expression is diminished in sinonasal tissues from patients with chronic rhinosinusitis with nasal polyps | 5.0 | 15 | Citations (PDF) |
| 119 | Evidence For Immunoglobulin D In Patients With Chronic Rhinosinusitis | 5.0 | 5 | Citations (PDF) |
| 120 | Asthmatics with exacerbation during acute respiratory illness exhibit unique transcriptional signatures within the nasal mucosa | 5.9 | 80 | Citations (PDF) |
| 121 | Transcriptomic signatures convergent across multiple studies of upper and lower airway allergic disease support the unified airway hypothesis (HUM7P.321) | 0.8 | 0 | Citations (PDF) |
| 122 | A role for anti-BP180 autoantibodies in chronic rhinosinusitis | 0.8 | 38 | Citations (PDF) |
| 123 | Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression | 5.0 | 128 | Citations (PDF) |
| 124 | B-lymphocyte lineage cells and the respiratory system | 5.0 | 161 | Citations (PDF) |
| 125 | Endotypes and phenotypes of chronic rhinosinusitis: A PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology | 5.0 | 530 | Citations (PDF) |
| 126 | Glucocorticoid receptor translational isoforms underlie maturational stage-specific glucocorticoid sensitivities of dendritic cells in mice and humans FreeBlood, 2013, 121, 1553-1562 | 5.3 | 74 | Citations (PDF) |
| 127 | Genetics of chronic rhinosinusitis: State of the field and directions forward | 5.0 | 116 | Citations (PDF) |
| 128 | Incidence and associated premorbid diagnoses of patients with chronic rhinosinusitis | 5.0 | 242 | Citations (PDF) |
| 129 | Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis | 5.0 | 258 | Citations (PDF) |
| 130 | Regional differences in the expression of innate host defense molecules in sinonasal mucosa | 5.0 | 34 | Citations (PDF) |
| 131 | Blockade of peanut allergy with a novel Ara h 2–Fcγ fusion protein in mice | 5.0 | 40 | Citations (PDF) |
| 132 | Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps | 5.0 | 129 | Citations (PDF) |
| 133 | Role of interleukin-32 in chronic rhinosinusitis | 1.5 | 11 | Citations (PDF) |
| 134 | Selective glucocorticoid receptor translational isoforms reveal glucocorticoid-induced apoptotic transcriptomes | 6.6 | 59 | Citations (PDF) |
| 135 | American Journal of Respiratory and Critical Care Medicine | 5.0 | 170 | Citations (PDF) |
| 136 | American Journal of Respiratory Cell and Molecular Biology | 2.1 | 44 | Citations (PDF) |
| 137 | Increased expression of CC chemokine ligand 18 in patients with chronic rhinosinusitis with nasal polyps | 5.0 | 90 | Citations (PDF) |
| 138 | Age-related differences in the pathogenesis of chronic rhinosinusitis | 5.0 | 70 | Citations (PDF) |
| 139 | Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps | 5.0 | 148 | Citations (PDF) |
| 140 | Airway epithelial cells activate TH2 cytokine production in mast cells through IL-1 and thymic stromal lymphopoietin | 5.0 | 125 | Citations (PDF) |
| 141 | Association of elevated plasminogen activator inhibitor 1 levels with diminished lung function in patients with asthma | 0.9 | 30 | Citations (PDF) |
| 142 | Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps | 5.0 | 110 | Citations (PDF) |
| 143 | Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps | 5.0 | 186 | Citations (PDF) |
| 144 | Chronic rhinosinusitis in the setting of other chronic inflammatory diseases | 0.9 | 51 | Citations (PDF) |
| 145 | Characterization of Specific Antibody Deficiency in Adults with Medically Refractory Chronic Rhinosinusitis | 1.6 | 70 | Citations (PDF) |
| 146 | Association between Severity of Asthma and Degree of Chronic Rhinosinusitis | 1.6 | 199 | Citations (PDF) |
| 147 | American Journal of Respiratory Cell and Molecular Biology | 2.1 | 142 | Citations (PDF) |
| 148 | Atopic profile of patients failing medical therapy for chronic rhinosinusitis†‡ | 2.1 | 100 | Citations (PDF) |
| 149 | Perspectives on the etiology of chronic rhinosinusitis | 0.8 | 96 | Citations (PDF) |
| 150 | Evaluation of the Presence of B-cell attractant Chemokines in Chronic Rhinosinusitis | 1.6 | 81 | Citations (PDF) |
| 151 | Substance P downregulates expression of the high affinity IgE receptor (FcεRI) by human mast cells | 1.8 | 27 | Citations (PDF) |
| 152 | Substance P primes lipoteichoic acid- and Pam3CysSerLys4-mediated activation of human mast cells by up-regulating Toll-like receptor 2 | 3.0 | 59 | Citations (PDF) |
| 153 | Elevated CO2 selectively inhibits interleukin-6 and tumor necrosis factor expression and decreases phagocytosis in the macrophage | 2.3 | 126 | Citations (PDF) |
| 154 | Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps | 5.0 | 154 | Citations (PDF) |
| 155 | Evidence for diminished levels of epithelial psoriasin and calprotectin in chronic rhinosinusitis | 5.0 | 115 | Citations (PDF) |
| 156 | Impairing oral tolerance promotes allergy and anaphylaxis: A new murine food allergy model | 5.0 | 157 | Citations (PDF) |
| 157 | Local release of B cell-activating factor of the TNF family after segmental allergen challenge of allergic subjects. | 5.0 | 44 | Citations (PDF) |
| 158 | Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis | 5.0 | 186 | Citations (PDF) |
| 159 | Adenosine receptor A2a inhibits complement-mediated activation of human mast cells by activating Gαs-proteins (139.5) | 0.8 | 1 | Citations (PDF) |
| 160 | Regulation and function of newly-recognized IL-1 family cytokines in human bronchial epithelial cells (98.18) | 0.8 | 2 | Citations (PDF) |
| 161 | Neuropeptides activate human mast cell degranulation and chemokine production | 3.0 | 426 | Citations (PDF) |
| 162 | Induction of B7-H1 and B7-DC expression on airway epithelial cells by the Toll-like receptor 3 agonist double-stranded RNA and human rhinovirus infection: and studies | 5.0 | 49 | Citations (PDF) |
| 163 | Evidence of a role for B cell–activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps | 5.0 | 175 | Citations (PDF) |
| 164 | 12/15-Lipoxygenase deficiency protects mice from allergic airways inflammation and increases secretory IgA levels | 5.0 | 76 | Citations (PDF) |
| 165 | Epithelial Genes in Chronic Rhinosinusitis with and without Nasal Polyps | 2.5 | 80 | Citations (PDF) |
| 166 | Perspectives on the Etiology of Chronic Rhinosinusitis: An Immune Barrier Hypothesis | 2.5 | 284 | Citations (PDF) |
| 167 | Epithelium: at the interface of innate and adaptive immune responses. | 5.0 | 362 | Citations (PDF) |
| 168 | Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity | 3.7 | 321 | Citations (PDF) |
| 169 | Altered Expression of Genes Associated with Innate Immunity and Inflammation in Recalcitrant Rhinosinusitis with Polyps | 2.5 | 104 | Citations (PDF) |
| 170 | Serum Amyloid A, Properdin, Complement 3, and Toll-Like Receptors are Expressed Locally in Human Sinonasal Tissue | 2.5 | 69 | Citations (PDF) |
| 171 | Superantigens and Chronic Rhinosinusitis: Skewing of T-Cell Receptor Vβ-Distributions in Polyp-Derived CD4+ and CD8+ T Cells | 2.5 | 66 | Citations (PDF) |
| 172 | Airway Epithelial Cells Produce B Cell-Activating Factor of TNF Family by an IFN-β-Dependent Mechanism1 | 0.8 | 156 | Citations (PDF) |
| 173 | Superantigens and Chronic Rhinosinusitis: Detection of Staphylococcal Exotoxins in Nasal Polyps† | 0.8 | 126 | Citations (PDF) |
| 174 | Innate immune responses and chronic obstructive pulmonary disease: "Terminator" or "Terminator 2"? | 0.0 | 26 | Citations (PDF) |
| 175 | American Journal of Respiratory Cell and Molecular Biology | 2.1 | 139 | Citations (PDF) |
| 176 | American Journal of Respiratory Cell and Molecular Biology | 2.1 | 71 | Citations (PDF) |
| 177 | American Journal of Respiratory Cell and Molecular Biology | 2.1 | 451 | Citations (PDF) |
| 178 | Innate Immunity of the Sinonasal Cavity: Expression of Messenger RNA for Complement Cascade Components and Toll-like Receptors | 1.9 | 79 | Citations (PDF) |
| 179 | Retinoic acid inhibits interleukin-4-induced eotaxin production in a human bronchial epithelial cell line | 2.2 | 24 | Citations (PDF) |
| 180 | Assessment of signal transducer and activator of transcription 6 as a target of glucocorticoid action in human airway epithelial cells | 1.6 | 13 | Citations (PDF) |
| 181 | Epithelial responses in airway inflammation and immunity | 0.0 | 6 | Citations (PDF) |
| 182 | Detection and quantitation of fatty acid acyl conjugates of triamcinolone acetonide via gas chromatography–electron-capture negative-ion mass spectrometry | 2.0 | 16 | Citations (PDF) |
| 183 | American Journal of Respiratory Cell and Molecular Biology | 2.1 | 43 | Citations (PDF) |
| 184 | Expression of Activation Markers on Alveolar Macrophages in Allergic Asthmatics after Endobronchial or Whole-Lung Allergen Challenge | 1.3 | 47 | Citations (PDF) |
| 185 | Review of the Molecular and Cellular Mechanisms of Action of Glucocorticoids for Use in Asthma | 1.9 | 130 | Citations (PDF) |
| 186 | Mast cells, basophils, and eosinophils: distinct but overlapping pathways for recruitment | 6.0 | 160 | Citations (PDF) |
| 187 | Measurement of Low Picomolar Levels of Triamcinolone Acetonide in Human Bronchoalveolar Lavage Fluid by Gas Chromatography-Electron-Capture Negative-Ion Mass Spectrometry | 2.0 | 9 | Citations (PDF) |
| 188 | American Journal of Respiratory Cell and Molecular Biology | 2.1 | 169 | Citations (PDF) |
| 189 | RNA Is Closely Associated with Human Mast Cell Secretory Granules, Suggesting a Role(s) for Granules in Synthetic Processes | 0.8 | 32 | Citations (PDF) |
| 190 | Endogenous glucocorticoids and antigen-induced acute and late phase pulmonary responses | 1.6 | 26 | Citations (PDF) |
| 191 | The effects of inhaled budesonide on circulating eosinophil progenitors and their expression of cytokines after allergen challenge in subjects with atopic asthma. | 5.0 | 46 | Citations (PDF) |
| 192 | The anti-inflammatory profile of inhaled corticosteroids: biopsy studies in asthmatic patients. | 1.8 | 14 | Citations (PDF) |
| 193 | A Mass Balance Study to Evaluate the Biotransformation and Excretion of [14C]-Triamcinolone Acetonide following Oral Administration | 1.3 | 35 | Citations (PDF) |
| 194 | American Journal of Respiratory Cell and Molecular Biology | 2.1 | 57 | Citations (PDF) |
| 195 | American Journal of Respiratory Cell and Molecular Biology | 2.1 | 25 | Citations (PDF) |
| 196 | Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids. | 2.1 | 100 | Citations (PDF) |
| 197 | Chemokines and allergic disease | 5.0 | 151 | Citations (PDF) |
| 198 | An in vitro comparison of commonly used topical glucocorticoid preparations | 5.0 | 49 | Citations (PDF) |
| 199 | Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor. | 2.0 | 189 | Citations (PDF) |
| 200 | American Journal of Respiratory Cell and Molecular Biology | 2.1 | 12 | Citations (PDF) |
| 201 | American Journal of Respiratory Cell and Molecular Biology | 2.1 | 120 | Citations (PDF) |
| 202 | Protection by dexamethasone of the functional desensitization to β2-adrenoceptor-mediated responses in human lung mast cells | 4.8 | 38 | Citations (PDF) |
| 203 | Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps | 5.0 | 99 | Citations (PDF) |
| 204 | Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. | 5.0 | 154 | Citations (PDF) |
| 205 | Diamine oxidase-gold ultrastructural localization of histamine in isolated human lung mast cells stimulated to undergo anaphylactic degranulation and recovery in vitro | 1.7 | 14 | Citations (PDF) |
| 206 | American Journal of Respiratory and Critical Care Medicine | 5.0 | 8 | Citations (PDF) |
| 207 | The epithelium as a target of glucocorticoid action in the treatment of asthma. | 5.0 | 67 | Citations (PDF) |
| 208 | Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. | 0.8 | 215 | Citations (PDF) |
| 209 | Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. | 2.2 | 151 | Citations (PDF) |
| 210 | Antiinflammatory steroids inhibit granulocyte/macrophage colony-stimulating factor production by human lung tissue | 2.0 | 21 | Citations (PDF) |
| 211 | Simultaneous Quantitation of Endogenous Levels of Cortisone and Cortisol in Human Nasal and Bronchoalveolar Lavage Fluids and Plasma via Gas Chromatography-Negative Ion Chemical Ionization Mass Spectrometry | 2.0 | 36 | Citations (PDF) |
| 212 | Application of a flow cytometric method using autofluorescence and a tandem fluorescent dye to analyze human alveolar macrophage surface markers | 1.0 | 31 | Citations (PDF) |
| 213 | The role of adhesion molecules in human eosinophil and basophil recruitment | 5.0 | 213 | Citations (PDF) |
| 214 | Function and expression of adhesion molecules on human basophils | 5.0 | 22 | Citations (PDF) |
| 215 | The effects of glucocorticoids on human eosinophils | 5.0 | 213 | Citations (PDF) |
| 216 | An overview of glucocorticoid anti-inflammatory actions | 1.7 | 175 | Citations (PDF) |
| 217 | Regulation of Lung Inflammation by Local Glucocorticoid Metabolism: An Hypothesis | 1.1 | 3 | Citations (PDF) |
| 218 | IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. | 0.8 | 727 | Citations (PDF) |
| 219 | Preliminary identification and role of phosphodiesterase isozymes in human basophils. | 0.8 | 78 | Citations (PDF) |
| 220 | American Review of Respiratory Disease | 3.1 | 61 | Citations (PDF) |
| 221 | Episodic eosinophilia-myalgia-like syndrome in a patient without L-tryptophan use: association with eosinophil activation and increased serum levels of granulocyte-macrophage colony-stimulating factor. | 5.0 | 44 | Citations (PDF) |
| 222 | Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. | 6.0 | 657 | Citations (PDF) |
| 223 | American Journal of Respiratory Cell and Molecular Biology | 2.1 | 55 | Citations (PDF) |
| 224 | Interleukin-1 is released at sites of human cutaneous allergic reactions. | 5.0 | 105 | Citations (PDF) |
| 225 | Flow cytometric methods for the analysis of human basophil surface antigens and viability | 1.0 | 69 | Citations (PDF) |
| 226 | Human endothelial cells prolong eosinophil survival. Regulation by cytokines and glucocorticoids. | 0.8 | 43 | Citations (PDF) |
| 227 | Inhibition of Lytic Programming by Pharmacologic Agentsa,b | 2.6 | 0 | Citations (PDF) |
| 228 | Pharmacokinetics of fentanyl as determined by radioimmunoassay | 2.7 | 72 | Citations (PDF) |
| 229 | Single-cell Transcriptomic Profiling Reveals Roles of Group 1 and 3 Innate Lymphoid Cells in Nasal Polyps | 5.0 | 0 | Citations (PDF) |
